Atlas Trials

Effect of Rosuvastatin Therapy on HDL2 Level

Clinical trial NCT02593487 · UNKNOWN

Trial details

NCT number
NCT02593487
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HyperlipemiaCoronary Heart Disease
Start date
2015-11-01
Primary completion
2016-12-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.